國立虎尾科技大學 |

Neuropsychiatric systemic lupus erythematosus = pathogenesis, clinical aspects and treatment /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Neuropsychiatric systemic lupus erythematosus/ edited by Shunsei Hirohata.
其他題名:	pathogenesis, clinical aspects and treatment /
其他作者:	Hirohata, Shunsei.
出版者:	Cham :Springer International Publishing : : 2018.,
面頁冊數:	viii, 189 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Systemic lupus erythematosus. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-76496-2
ISBN:	9783319764962

Neuropsychiatric systemic lupus erythematosus = pathogenesis, clinical aspects and treatment /
Neuropsychiatric systemic lupus erythematosuspathogenesis, clinical aspects and treatment /[electronic resource] :edited by Shunsei Hirohata. - Cham :Springer International Publishing :2018. - viii, 189 p. :ill., digital ;24 cm.

1 Epidemiology -- 2 Genetics -- 3 Immunology and pathogenesis -- 4 Pathology -- 5 Clinical Features -- 6 Cytokine -- 7 Diagnosis and Differential diagnosis -- 8 Imaging of NPSLE -- 9 Psychiatric symptoms -- 10 Treatment -- 11 Promising treatment alternatives -- 12 Prognosis.

Neuropsychiatric manifestation in systemic lupus erythematosus (NPSLE) is one of the most recalcitrant complications of the disease. According to the 1999 ACR nomenclature and case definitions, diffuse psychiatric/neuropsychological syndromes in NPSLE (anxiety disorder, acute confusional state, cognitive dysfunction, mood disorder, psychosis) (diffuse NPSLE) present psychiatric manifestations unlike neurologic syndromes (focal NPSLE) originating from focal CNS lesions, such as cerebrovascular disease, demyelinating syndrome, headache, aseptic meningitis, chorea, seizures and myelopathy. A number of studies have reported that diffuse NPSLE is usually associated with the presence of autoantibodies against neuronal cells in serum as well as in cerebrospinal fluid (CSF). Moreover, IL-6 has been shown to be elevated in CSF of patients with diffuse NPSLE. Recently, it has been demonstrated that the severity of blood-brain barrier damages plays a crucial role in the development of acute confusional state, the severest form of diffuse NPSLE through the accelerated entry of larger amounts of autoantibodies to NMDA receptor subunit NR2 into the CNS. Since the importance of autoantibodies in the NPSLE has been now evident, such an aggressive treatment, especially B cell depleting therapy, would make sense in that it would reduce the levels of pathogenic autoantibodies, leading to a better prognosis of NPSLE. As far as we know, no single book specifically dedicated to NPSLE alone has been published as yet. As mentioned above, NPSLE constitutes a vastly expanding field of research with increasing numbers of papers published annually. Therefore, we believe that an effort to collect and critically review these publications is invaluable. Such an effort will provide an important contribution to basic researchers as well as clinicians working in the field of neurology, rheumatology, psychiatry and internal medicine fields.

ISBN: 9783319764962

Standard No.: 10.1007/978-3-319-76496-2doiSubjects--Topical Terms:

644291
Systemic lupus erythematosus.

LC Class. No.: RC924.5.L85

Dewey Class. No.: 616.772

Neuropsychiatric systemic lupus erythematosus = pathogenesis, clinical aspects and treatment /
LDR:03209nam a2200313 a 4500 001 924548
003 DE-He213
005 20180830170932.0
006 m d
007 cr nn 008maaau
008 190625s2018 gw s 0 eng d
020 $a 9783319764962 $q (electronic bk.)
020 $a 9783319764955 $q (paper)
024 7 $a 10.1007/978-3-319-76496-2 $2 doi
035 $a 978-3-319-76496-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC924.5.L85
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 616.772 $2 23
090 $a RC924.5.L85 $b N494 2018
245 0 0 $a Neuropsychiatric systemic lupus erythematosus $h [electronic resource] : $b pathogenesis, clinical aspects and treatment / $c edited by Shunsei Hirohata.
260 $a Cham : $c 2018. $b Springer International Publishing : $b Imprint: Springer,
300 $a viii, 189 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1 Epidemiology -- 2 Genetics -- 3 Immunology and pathogenesis -- 4 Pathology -- 5 Clinical Features -- 6 Cytokine -- 7 Diagnosis and Differential diagnosis -- 8 Imaging of NPSLE -- 9 Psychiatric symptoms -- 10 Treatment -- 11 Promising treatment alternatives -- 12 Prognosis.
520 $a Neuropsychiatric manifestation in systemic lupus erythematosus (NPSLE) is one of the most recalcitrant complications of the disease. According to the 1999 ACR nomenclature and case definitions, diffuse psychiatric/neuropsychological syndromes in NPSLE (anxiety disorder, acute confusional state, cognitive dysfunction, mood disorder, psychosis) (diffuse NPSLE) present psychiatric manifestations unlike neurologic syndromes (focal NPSLE) originating from focal CNS lesions, such as cerebrovascular disease, demyelinating syndrome, headache, aseptic meningitis, chorea, seizures and myelopathy. A number of studies have reported that diffuse NPSLE is usually associated with the presence of autoantibodies against neuronal cells in serum as well as in cerebrospinal fluid (CSF). Moreover, IL-6 has been shown to be elevated in CSF of patients with diffuse NPSLE. Recently, it has been demonstrated that the severity of blood-brain barrier damages plays a crucial role in the development of acute confusional state, the severest form of diffuse NPSLE through the accelerated entry of larger amounts of autoantibodies to NMDA receptor subunit NR2 into the CNS. Since the importance of autoantibodies in the NPSLE has been now evident, such an aggressive treatment, especially B cell depleting therapy, would make sense in that it would reduce the levels of pathogenic autoantibodies, leading to a better prognosis of NPSLE. As far as we know, no single book specifically dedicated to NPSLE alone has been published as yet. As mentioned above, NPSLE constitutes a vastly expanding field of research with increasing numbers of papers published annually. Therefore, we believe that an effort to collect and critically review these publications is invaluable. Such an effort will provide an important contribution to basic researchers as well as clinicians working in the field of neurology, rheumatology, psychiatry and internal medicine fields.
650 0 $a Systemic lupus erythematosus. $3 644291
650 0 $a Neurobehavioral disorders. $3 644588
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Neurosciences. $3 593561
650 2 4 $a Immunology. $3 592892
700 1 $a Hirohata, Shunsei. $3 1201642
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-76496-2
950 $a Biomedical and Life Sciences (Springer-11642)